Generics Industry News Search
 |
|
|
|
|
|
|
December 2006 News Archive |
|
|
| |
|
Gurgaon (Haryana) India, December 01, 2006: Ranbaxy Laboratories Limited (Ranbaxy), India’s largest pharmaceutical company, today announced the acquisition of Be-Tabs Pharmaceuticals (Pty) Limited (“Be-Tabs”), in South Africa, for a total consideration of USD 70 Million (500 Million ZAR). ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Dec 4, 2006 - Savient Pharmaceuticals, Inc. announced today that it has filed a lawsuit in the U.S. District Court for the District of New Jersey against Sandoz Pharmaceuticals, a Novartis Pharmaceuticals company (NYSE: NVS), ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
RICHMOND, Va.--(BUSINESS WIRE)--Dec 6, 2006 - Insmed, Inc. (NASDAQ:INSM) announced today that the company was found by a jury in the U.S. District Court for the Northern District of California to have infringed on patents held by Genentech, Inc. and Tercica, Inc....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Dec 6, 2006 - Akorn, Inc. and Strides Arcolab Limited (NSE: STAR, BSE: 532531) today announced that both Companies have agreed to fund, develop, and commercialize an additional 10 ANDA injectable drug products for the Akorn-Strides, LLC Joint Venture....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
WILMINGTON, MASSACHUSETTS--(CCNMatthews - Dec. 8, 2006) - DUSA Pharmaceuticals, Inc.(R) reported today that River's Edge Pharmaceuticals, LLC filed a motion late yesterday to lift the preliminary injunction...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
PARIS and NEW YORK, December 08, 2006 /PRNewswire-FirstCall/ -- Sanofi-aventis and Bristol-Myers Squibb Company (the companies) announced today that the United States Court of Appeals for the Federal Circuit has upheld ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
NEW YORK, December 08, 2006 /PRNewswire-FirstCall/ -- Pfizer Inc announced today that the Canadian Federal Court in Toronto has granted its application for an order preventing Novopharm Ltd. from launching a generic version of Lipitor until expiration of the product's patent ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Dec 11, 2006 - Savient Pharmaceuticals, Inc. announced today that the U.S. District Court for the District of New Jersey, after considering legal briefs and supporting affidavits from all parties,...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
SPOKANE, Wash., December 13, 2006 /PRNewswire/ -- HollisterStier Contract Manufacturing signed a manufacturing contract with GeneraMedix Inc. to develop a process for compounding and lyophilizing multiple generic drug products. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
WOODCLIFF LAKE, N.J., Dec. 13 /PRNewswire-FirstCall/ -- Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc., today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food & Drug Administration (FDA) to manufacture and market a generic version of Celgene Corporation's Thalomid(R) (thalidomide) Capsules, 200 mg....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Gurgaon, India, December 14, 2006 - Ranbaxy Laboratories Limited (RLL), announced today that the Company has received approval from the U.S. Food and Drug Administration to manufacture and market Cefprozil Tablets USP, 250 mg and 500 mg. The Office of Generic Drugs,...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pharma company Krka has scored a victory in its ongoing legal battle with French company Sanofi Aventis in Serbia, as a higher court overturned a ban on sales of its anticoagulant Zyllt imposed in November by a court of first instance. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IRVINE, Calif.-(Business Wire)-December 15, 2006 - Anchen Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application to market its generic version of Biovail Corporation's anti-depressant Wellbutrin XL(R) (Bupropion hydrochloride) Extended-Release Tablets, 150 mg and 300 mg. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Barcelona, December 15 2006.- Spanish company Medichem S.A., one of the world’s leading manufacturers of Active Ingredients for the pharmaceutical industry, has recently passed an US Food and Drug Administration (FDA) inspection without any observation for the third consecutive time...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
DETROIT, Dec 15, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Caraco Pharmaceutical Laboratories, Ltd. announced today that it will market Extended Phenytoin Sodium Capsules, USP 100mg (Phenytoin ER) on behalf of Sun Pharmaceutical Industries, Ltd....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
From 2009, generic drugs produced cheaply in Vietnam must prove they are equivalent to the patented medicines on which they are modeled, authorities have said....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca monopoly on top-selling drug Nexium will be in the spotlight next week when the European Patent Office hears an appeal over the product's patent on December 19. The substance-of-matter patent that protects the heartburn and antiulcerant pill was already upheld once in November 2003 following a challenge by German generic drug manufacturer Ratiopharm....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
I recently came across a press release from WiDO (Wissenschaftlichen Institut der AOK) which translates as the AOK Scientific Institute. The AOK is the overall association of the German sick funds and it was announcing the publication of a report entitled “Arzneiverordnungs-Report 2006”....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
Product Launched Under Exclusivity Transfer Agreement with Anchen and Teva
HAYWARD, Calif.--(BUSINESS WIRE)--Dec. 18, 2006--IMPAX Laboratories, Inc. announced today that the U.S. Food and Drug Administration (FDA)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
Abbott Laboratories has lost a bid to stop Novartis AG's Sandoz unit from selling a generic copy of the extended release version of the antibiotic Biaxin.
U.S. District Judge David H....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
BALTIMORE, December 19, 2006 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Trandolapril Tablets,...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
CHADDS FORD, PA, Dec 19, 2006 (MARKET WIRE via COMTEX News Network) -- Endo Pharmaceuticals Holdings Inc. announced today the submission of a Citizen Petition with the U.S. Food and Drug Administration requesting that the FDA apply existing bioequivalence regulations to any Abbreviated New Drug Application ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
PITTSBURGH, Dec. 19 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Finasteride Tablets USP, 5mg....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Pfizer's Representation to the Australian Patent Office Held to be False & Misleading. Overall Ruling Mixed as Court Also Upholds Another Pfizer Patent ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
EXETER, N.H.--(BUSINESS WIRE)--Dec 21, 2006 - Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, announced today that its U.S. marketing partner, Perrigo Company, has received approval ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
ROCKVILLEE, Md., Dec. 21, 2006--The Food and Drug Administration, on December 19, 2006, granted tentative approval for efavirenz Capsules, 50 mg, 100 mg, and 200 mg., manufactured by Aurobindo Pharma Limited Inc., of Hyderabad, India....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Laboratories Limited (RLL), announced today that the Company has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Simvastatin Tablets USP, 5 mg, 10 mg, 20 mg and 40 mg in the U.S. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
ALLEGAN, Mich., December 21, 2006 /PRNewswire-FirstCall/ -- The Perrigo Company today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market Simvastatin Tablets, USP, 5 mg, 10 mg, 20 mg, 40 mg and 80 mg. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
NORTH WALES, Penn., Dec. 20, 2006 – Teva Pharmaceuticals is pleased to announce the introduction and availability of Simvastatin Tablets USP, 80 mg. This product is AB rated and bioequivalent to Zocor®* Tablets....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IRVINE, Calif., Dec. 21 /PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) announced today that patent litigation relating to sumatriptan injection, the generic version of GlaxoSmithKline's(R) Imitrex(R) Injection, ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
PITTSBURGH, Dec. 21 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. (NYSE: MYL) today announced that it has completed its acquisition of 20% of the fully diluted voting equity capital of Matrix Laboratories Limited, at a price of Rs. 306 per share...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
BEDFORD, OH – December 26, 2006 – Bedford Laboratories™, a division of Ben Venue Laboratories Inc., announced that it will begin marketing Ondansetron Injection USP as of December 26, 2006....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
HYDERABAD, India--(BUSINESS WIRE)--Dec 27, 2006 - Dr. Reddy's Laboratories Limited (NYSE:RDY) announced today, that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Ondansetron Hydrochloride Tablets, ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
LAKE FOREST, Ill., Dec. 26, 2006 -- Hospira, Inc. (NYSE:HSP), a leading global hospital products company, today announced the launch of ondansetron injection. The medication is the generic version of GlaxoSmithKline's Zofran®, ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
INDIANAPOLIS, December 26, 2006 /PRNewswire-FirstCall/ -- The Court of Appeals for the Federal Circuit in Washington, D.C., today affirmed the U.S. District Court's decision that upheld Eli Lilly and Company's Zyprexa(R) patent expiring in 2011....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
SUMMIT, N.J., December 26, 2006 /PRNewswire-FirstCall/ -- Celgene Corporation announced that the Company has been notified of an Abbreviated New Drug Application (ANDA) filed with the U.S. Food and Drug Administration (FDA), with a Paragraph IV certification, by Barr Pharmaceuticals, Inc. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
WOODCLIFF LAKE, N.J., December 26, 2006 /PRNewswire-FirstCall/ -- Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc. , today confirmed that it is seeking approval from the U.S. Food & Drug Administration...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
BEDFORD, Ohio, Dec. 26 /PRNewswire/ -- Bedford Laboratories(TM), a division of Ben Venue Laboratories Inc., announced that it will begin marketing Ondansetron Injection USP as of December 26, 2006, 2006. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Par to Manufacture, Barr Pharmaceuticals Inc.'s PLIVA Subsidiary to Market Product;...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
ROCKVILLE, Md., Dec. 27, 2006-The Food and Drug Administration today approved the first generic versions of Zofran (Ondansetron) Tablets, Orally Disintegrating Tablets and Oral Solution which are indicated to prevent nausea and vomiting associated with surgery, radiotherapy and cancer chemotherapy. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
CORAL SPRINGS, Fla., December 28, 2006 /PRNewswire/ -- Boca Pharmacal, Inc. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
PARIS and NEW YORK, December 28, 2006 /PRNewswire-FirstCall/ -- Sanofi-aventis and Bristol-Myers Squibb announced today that the Canadian Federal Court of Appeals dismissed Apotex Inc.'s (Apotex) appeal of the judgment of the Federal Court of Canada prohibiting the Minister of Health from issuing a Notice of Compliance to Apotex in connection with its 75mg clopidogrel bisulfate tablets. Absent a Notice of Compliance, Apotex cannot market its 75mg clopidogrel bisulfate tablets in Canada. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
FAIRFIELD, N.J., December 29, 2006 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, Inc. reported today that A. Aarons, Inc., a subsidiary of Bradley Pharmaceuticals, has announced the launch of methscopolamine bromide tablets, an authorized generic of the Company's Pamine(R) tablets....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Dec 29, 2006 - Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) (Savient or the Company) announced today that Watson Pharmaceuticals (NYSE:WPI), under the terms of its previous supply and distribution agreement with Savient, ...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
